{"database": "openregs", "table": "documents", "rows": [["FDA-2011-N-0802-0001", "FDA", "FDA-2011-N-0802", "Role of Naloxone in OpioidOverdose Fatality Prevention; Workshop; Request for Comments", "Notice", "Meeting", "2011-11-17T05:00:00Z", 2011, 11, "2011-11-17T05:00:00Z", "2012-06-13T03:59:59Z", "2012-06-14T02:02:30Z", "2011-29703", 0, 0, "0900006480f6e632"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2011-N-0802-0001"], "units": {}, "query_ms": 37.245269981212914, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}